PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 20, 2019Journal of Thoracic OncologyOpen Access

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

View Full Paper
Ask AI
Bookmark
Share

Authors

D. Ross Camidge
D. Ross CamidgeAstraZeneca (United Kingdom)RDRafał DziadziuszkoUniversity of Gdańsk
Solange Peters
Solange PetersGoethe University Frankfurt

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Camidge et al. (2019) studied this question.

synapsesocial.com/papers/69d7c6f005ee2ba81dbede09https://doi.org/10.1016/j.jtho.2019.03.007
View Full Paper
Ask AI
Bookmark
Share